CLINICAL_TRIALS
trial_result
· 2018-05-18
Clinical Trial Update: A Study in Non Small Cell Lung Cancer [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial in non-small cell lung cancer sponsored by Eli Lilly has completed, with results posted on May 18, 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eli Lilly and Company | Conditions: Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-05-18